Ray Dalio’s MET Holdings & Trades

First Buy
Q2 2013
Duration Held
50 Quarters
Largest Add
Q4 2024
+721,344 Shares
Current Position
1.66 M Shares
$136.57 M Value

Ray Dalio's MET Position Overview

Ray Dalio (via Bridgewater Associates, Lp) currently holds 1.66 M shares of MetLife, Inc. (MET) worth $136.57 M, representing 0.53% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.

Based on 13F filings since 2013, Ray Dalio has maintained a long-term strategic position in MET, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2024, adding 721,344 shares. Largest reduction occurred in Q2 2017, reducing 454,554 shares.

Analysis based on 13F filings available since 2013 Q2

Ray Dalio's MetLife (MET) Holding Value Over Time

Track share changes against reported price movement

Quarterly MetLife (MET) Trades by Ray Dalio

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2013 +136,732 Add 0.00% 136,731 $40.78
Q3 2013 +60,364 Add 44.15% 197,095 $41.84
Q4 2013 -197,095 Sold Out 197,095 $0.00
Q1 2014 +88,598 New Buy 88,598 $47.06
Q2 2014 +12,678 Add 14.31% 101,276 $49.52
Q3 2014 +25,245 Add 24.93% 126,521 $47.88
Q4 2014 +41,178 Add 32.55% 167,699 $48.21
Q1 2015 +250,184 Add 149.19% 417,883 $45.05
Q2 2015 -277,695 Reduce 66.45% 140,188 $49.90
Q3 2015 +42,636 Add 30.41% 182,824 $42.02
Q4 2015 -182,824 Sold Out 182,824 $0.00
Q1 2016 +90,932 New Buy 90,932 $39.16
Q2 2016 +374,748 Add 412.12% 465,680 $35.50
Q3 2016 -465,680 Sold Out 465,680 $0.00
Q2 2017 +11,126 New Buy 11,126 $48.98
Q3 2017 -11,126 Sold Out 11,126 $0.00
Q1 2018 +17,815 New Buy 17,815 $45.92
Q2 2018 +10,840 Add 60.85% 28,655 $43.59
Q3 2018 -28,655 Sold Out 28,655 $0.00
Q4 2018 +17,979 New Buy 17,979 $41.05
Q1 2019 -17,979 Sold Out 17,979 $0.00
Q2 2021 +12,478 New Buy 12,478 $59.87
Q3 2021 +379 Add 3.04% 12,857 $61.76
Q4 2021 -12,857 Sold Out 12,857 $0.00
Q1 2022 +146,037 New Buy 146,037 $70.28
Q2 2022 +302,574 Add 207.19% 448,611 $62.79
Q3 2022 -201,752 Reduce 44.97% 246,859 $60.78
Q4 2022 -125,679 Reduce 50.91% 121,180 $72.37
Q1 2023 +256,369 Add 211.56% 377,549 $57.94
Q2 2023 +202,224 Add 53.56% 579,773 $56.53
Q3 2023 -125,052 Reduce 21.57% 454,721 $62.91
Q4 2023 +126,076 Add 27.73% 580,797 $66.13
Q1 2024 -33,235 Reduce 5.72% 547,562 $74.11
Q2 2024 -136,687 Reduce 24.96% 410,875 $70.19
Q3 2024 +65,811 Add 16.02% 476,686 $82.48
Q4 2024 +721,344 Add 151.32% 1.2 M $81.88
Q1 2025 +590,573 Add 49.30% 1.79 M $80.29
Q2 2025 +101,299 Add 5.66% 1.89 M $80.42
Q3 2025 -231,863 Reduce 12.27% 1.66 M $82.37

Ray Dalio's MetLife Investment FAQs

Ray Dalio first purchased MetLife, Inc. (MET) in Q2 2013, acquiring 136,731 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ray Dalio has held MetLife, Inc. (MET) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ray Dalio's largest addition to MetLife, Inc. (MET) was in Q4 2024, adding 1,198,030 shares worth $98.09 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 1,658,039 shares of MetLife, Inc. (MET), valued at approximately $136.57 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, MetLife, Inc. (MET) represents approximately 0.53% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ray Dalio's peak holding in MetLife, Inc. (MET) was 1,889,902 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.